Empagliflozin and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: The EMPA-KIDNEY Trial

被引：0
|
作者：
Preiss, David [1 ]
Herrington, William [1 ]
Haynes, Richard [1 ]
机构：
[1] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England
来源：
CIRCULATION | 2022年 / 146卷 / 25期
关键词：
Sodium glucose co-transporter 2 inhibitors Chronic kidney disease; Cardiovascular disease Clinical trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19464
引用
收藏
页码：E577 / E577
页数：1
相关论文
共 50 条
  • [31] Cardiovascular disease in patients with chronic kidney disease
    Wright, Julian
    Hutchison, Alastair
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 713 - 722
  • [32] Cardiovascular disease in patients with chronic kidney disease
    Jaradat, MI
    Molitoris, BA
    SEMINARS IN NEPHROLOGY, 2002, 22 (06) : 459 - 473
  • [33] Cardiovascular disease in patients with chronic kidney disease
    Saritas, Turgay
    Floege, Juergen
    HERZ, 2020, 45 (02) : 122 - 128
  • [34] Cardiovascular disease in patients with chronic kidney disease
    Pilmore, Helen
    Dogra, Gursharan
    Roberts, Matthew
    Heerspink, Hiddo J. Lambers
    Ninomiya, Toshiharu
    Huxley, Rachel
    Perkovic, Vlado
    NEPHROLOGY, 2014, 19 (01) : 3 - 10
  • [35] Cardiovascular disease in patients with chronic kidney disease
    Marx, Nikolaus
    Floege, Juergen
    HERZ, 2021, 46 (03) : 205 - 205
  • [36] The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
    Heerspink, J. L.
    Wheeler, D. C.
    Vart, P.
    Jongs, N.
    Hou, F. F.
    Langkilde, A. M.
    Correa-Rotter, R.
    Rossing, P.
    Sjostrom, C. D.
    Toto, R. D.
    Chertow, G. M.
    Stefansson, B. V.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2913 - 2913
  • [37] FASTING THE MONTH OF RAMADAN FOR PATIENTS WITH CHRONIC KIDNEY DISEASE: IMPACT ON KIDNEY FUNCTION AND CARDIOVASCULAR OUTCOMES
    NasrAllah, Mohamed M.
    Osman, Noha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 153 - 153
  • [38] MARKERS FOR CHOLESTEROL METABOLISM AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Emrich, I.
    Rogacev, K.
    Luetjohann, D.
    Schulze, P. C.
    Boehm, M.
    Fliser, D.
    Heine, G.
    Weingaertner, O.
    ATHEROSCLEROSIS, 2020, 315 : E180 - E181
  • [39] Markers of cholesterol metabolism and cardiovascular outcomes in patients with chronic kidney disease
    Emrich, I
    Rogacev, K.
    Boehm, M.
    Schulze, P. C.
    Fliser, D.
    Heine, G. H.
    Luetjohann, D.
    Weingaertner, O.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3317 - 3317
  • [40] Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial
    Hopley, Charles W.
    Kavanagh, Sarah
    Patel, Manesh R.
    Ostrom, Cara
    Baumgartner, Iris
    Berger, Jeffrey S.
    Blomster, Juuso, I
    Fowkes, F. Gerry R.
    Jones, W. Schuyler
    Katona, Brian G.
    Mahaffey, Kenneth W.
    Norgren, Lars
    Rockhold, Frank W.
    Hiatt, William R.
    VASCULAR MEDICINE, 2019, 24 (05) : 422 - 430
12345